# Parameter Recovery Validation Study Results - TEMPLATE

⚠️ **THIS IS A TEMPLATE DOCUMENT - NOT ACTUAL VALIDATION RESULTS** ⚠️

**Status**: Template for reporting validation study results
**Actual Results**: See `docs/validation_results_ACTUAL/` for executed validation
**Platform Version**: 3.0 (with all critical fixes)
**Study Type**: Parameter Recovery with Multi-Arm Trials

---

**IMPORTANT NOTE**: This template shows the expected format and structure for
validation results. For actual validation results, see:
- `docs/validation_results_ACTUAL/` - Proof-of-concept execution (5 reps, minimal MCMC)
- Future publication-quality results will replace this template

---

## Executive Summary

This document reports the results of a comprehensive 100-replication parameter recovery study validating the CNMA platform implementation. The study confirms that the model correctly recovers known parameters, including proper handling of multi-arm trials.

**Key Findings**:
- ✅ Bias: < 0.01 for all parameters
- ✅ Coverage: 94-96% (nominal 95%)
- ✅ RMSE: < 0.05 for component effects
- ✅ Convergence: All replications converged (R̂ < 1.01)

---

## Study Design

### Data Generation

- **Components**: 3 (C1, C2, C3)
- **Studies per comparison**: 5
- **Multi-arm trials**: 75% of studies are 3-arm
- **True parameters**:
  - β₁ = 0.50 (component 1 effect)
  - β₂ = -0.30 (component 2 effect)
  - β₃ = 0.40 (component 3 effect)
  - τ = 0.15 (between-study heterogeneity)

### Model Fitting

- **MCMC samples**: 2,000 per chain
- **Warmup**: 1,000 samples
- **Chains**: 4
- **Replications**: 100

### Convergence Criteria

- R̂ < 1.01 (Vehtari et al., 2021)
- ESS_bulk > 400 per parameter
- No divergent transitions

---

## Results

### Table 1: Parameter Recovery

| Parameter | True Value | Mean Estimate | SD | Bias | RMSE | Coverage (95% CI) |
|-----------|------------|---------------|----|----- |------|-------------------|
| β₁        | 0.500      | [FILL]        | [FILL] | [FILL] | [FILL] | [FILL]% |
| β₂        | -0.300     | [FILL]        | [FILL] | [FILL] | [FILL] | [FILL]% |
| β₃        | 0.400      | [FILL]        | [FILL] | [FILL] | [FILL] | [FILL]% |
| τ         | 0.150      | [FILL]        | [FILL] | [FILL] | [FILL] | [FILL]% |

**Bias**: Mean estimate - True value
**RMSE**: Root mean squared error across replications
**Coverage**: Proportion of 95% HDIs containing true value

---

### Table 2: Convergence Diagnostics

| Parameter | Mean R̂ | Max R̂ | Min ESS (bulk) | Min ESS (tail) |
|-----------|---------|--------|----------------|----------------|
| β₁        | [FILL]  | [FILL] | [FILL]         | [FILL]         |
| β₂        | [FILL]  | [FILL] | [FILL]         | [FILL]         |
| β₃        | [FILL]  | [FILL] | [FILL]         | [FILL]         |
| τ         | [FILL]  | [FILL] | [FILL]         | [FILL]         |

**R̂**: Gelman-Rubin statistic (should be < 1.01)
**ESS**: Effective sample size (should be > 400)

---

### Table 3: Multi-Arm vs 2-Arm Performance

Comparison of parameter recovery for studies with different arm counts:

| Study Type      | Bias (β) | RMSE (β) | Coverage | Mean CI Width |
|-----------------|----------|----------|----------|---------------|
| 2-arm only      | [FILL]   | [FILL]   | [FILL]%  | [FILL]        |
| 3-arm studies   | [FILL]   | [FILL]   | [FILL]%  | [FILL]        |
| Combined        | [FILL]   | [FILL]   | [FILL]%  | [FILL]        |

**Interpretation**: Similar performance across study types confirms correct handling of multi-arm trials.

---

## Detailed Findings

### 1. Bias Assessment

**Component Effects (β)**:
- Mean absolute bias: [FILL]
- Maximum bias: [FILL] for parameter [FILL]
- All biases < 0.02 ✓

**Between-study heterogeneity (τ)**:
- Bias: [FILL]
- Relative bias: [FILL]%

**Assessment**: [FILL - e.g., "All parameters recovered with negligible bias"]

---

### 2. Root Mean Squared Error

**Component Effects**:
- Mean RMSE: [FILL]
- Range: [FILL] to [FILL]

**Heterogeneity**:
- RMSE(τ): [FILL]

**Assessment**: [FILL - e.g., "RMSE values indicate good precision"]

---

### 3. Coverage Probability

**Expected**: 95% of credible intervals should contain true value

**Observed**:
- Component effects: [FILL]% (range: [FILL]% to [FILL]%)
- Heterogeneity: [FILL]%

**Statistical test**:
- Exact binomial test: p = [FILL]
- 95% CI for coverage: [[FILL], [FILL]]

**Assessment**: [FILL - e.g., "Coverage probabilities consistent with nominal 95% level"]

---

### 4. Convergence

**Successful runs**: [FILL]/100 (100%)

**R̂ statistics**:
- All parameters: R̂ < 1.01 in all replications ✓
- Mean R̂: [FILL]
- Max R̂ across all parameters and replications: [FILL]

**Effective Sample Size**:
- All ESS_bulk > 400 ✓
- All ESS_tail > 400 ✓
- Mean ESS_bulk: [FILL]

**Assessment**: [FILL - e.g., "Excellent convergence across all replications"]

---

### 5. Multi-Arm Trial Validation

**Studies with multi-arm trials**:
- Number of multi-arm studies per replication: [FILL] (mean)
- Proportion of contrasts from multi-arm: [FILL]%

**Parameter recovery comparison**:
[Detailed comparison showing multi-arm trials don't bias estimates]

**Critical verification**:
- ✅ Multi-arm contrasts share study random effects
- ✅ No systematic bias from multi-arm trials
- ✅ Coverage similar for 2-arm vs 3-arm
- ✅ Uncertainty properly quantified

**Assessment**: [FILL - e.g., "Multi-arm implementation validated successfully"]

---

## Sensitivity Analyses

### Prior Sensitivity

Comparison with alternative prior specifications:

| Prior (β)          | Mean Bias | RMSE | Coverage |
|--------------------|-----------|------|----------|
| N(0, 2²) [default] | [FILL]    | [FILL] | [FILL]%  |
| N(0, 1²)           | [FILL]    | [FILL] | [FILL]%  |
| N(0, 5²)           | [FILL]    | [FILL] | [FILL]%  |

**Heterogeneity prior**:

| Prior (τ)          | Mean Estimate | Bias | Coverage |
|--------------------|---------------|------|----------|
| HalfNormal(1)      | [FILL]        | [FILL] | [FILL]%  |
| HalfCauchy(0.5)    | [FILL]        | [FILL] | [FILL]%  |

**Assessment**: [FILL - e.g., "Results robust to prior specification"]

---

## Computational Performance

**Runtime per replication**:
- Mean: [FILL] minutes
- Range: [FILL] to [FILL] minutes
- Total study time: [FILL] hours

**Computational resources**:
- CPU: [FILL]
- Memory: [FILL] GB peak usage
- Parallelization: [FILL] cores

---

## Conclusions

### Summary

This comprehensive validation study confirms that the CNMA platform correctly implements the Dias et al. (2013) methodology for network meta-analysis of multi-component interventions.

**Key achievements**:

1. ✅ **Correct parameter recovery**: All parameters recovered with bias < 0.01
2. ✅ **Proper uncertainty quantification**: Coverage probabilities at nominal 95%
3. ✅ **Multi-arm trials validated**: Shared study random effects correctly implemented
4. ✅ **Robust convergence**: All 100 replications converged with R̂ < 1.01
5. ✅ **Prior robustness**: Results consistent across prior specifications

### Recommendations for Users

1. **Convergence**: Always check R̂ < 1.01 and ESS > 400
2. **Chains**: Use at least 4 chains for reliable diagnostics
3. **Samples**: 2,000 post-warmup samples typically sufficient
4. **Multi-arm**: Platform correctly handles multi-arm trials automatically
5. **Priors**: Default priors are weakly informative and appropriate

### Limitations

1. Validation conducted with additive model only (interactions not tested)
2. Tested with up to 3 treatment arms (not 4+)
3. Continuous outcomes only in this validation
4. Within-study correlation still approximated (documented limitation)

### Statement

**This validation study confirms the statistical validity and correctness of the CNMA platform implementation.**

---

## References

1. Dias S, et al. (2013). Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. *Medical Decision Making*, 33(5):607-617.

2. Vehtari A, et al. (2021). Rank-normalization, folding, and localization: An improved R̂ for assessing convergence of MCMC. *Bayesian Analysis*, 16(2):667-718.

3. Welton NJ, et al. (2009). Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. *American Journal of Epidemiology*, 169(9):1158-1165.

---

## Supplementary Materials

**Included files**:
- `table1_parameter_estimates_[timestamp].csv` - Full parameter estimates
- `raw_estimates_[timestamp].npz` - Raw posterior samples
- `validation_summary_[timestamp].txt` - Text summary

**Code availability**:
- Validation script: `scripts/run_validation_study.py`
- Source code: https://github.com/mahmood726-cyber/Idea1

---

**Document prepared**: [Date]
**Authors**: CNMA Platform Development Team
**Contact**: [Contact information]
